查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627744

全球采血采血针市场：预测（2025-2030）

Blood lancets market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球采血采血针市场规模预计将从2025年的20.5亿美元增加至2030年的30.83亿美元，复合年增长率为8.50%。

采血采血针是一种小型医疗器械，用于运输血液样本或收集小检体进行测试。全球糖尿病和其他感染疾病的增加正在推动预测期内的市场成长。

然而，新兴国家缺乏报销方案预计将限制未来几年的市场扩张。

血液采血针市场驱动因素：

  • 糖尿病盛行率上升推动市场成长

糖尿病盛行率的上升预计将成为预测期内市场成长的主要驱动力之一。根据2021年版第10版IDF糖尿病地图集，2021年将有5.37亿成年人（20-79岁）患有糖尿病。 2030年，全球将有6.43亿糖尿病患者，到2045年，这一数字将增加至7.83亿。此外，5.41 亿成年人可能患有第 2 型糖尿病。此外，糖尿病日益增加的经济负担加上医疗支出的增加预计将增加未来几年对血糖监测快速诊断试剂套件的需求。根据国际糖尿病联盟（IDF）统计，2021年全球糖尿病医疗支出约9,660亿美元，成长9%，直接推动市场成长。

采血采血针市场地理前景

按地区划分，采血采血针市场分为北美、南美、欧洲、中东和非洲以及亚太地区。亚太地区由中国、日本、印度和韩国等主要经济体主导。一些成长最快的新兴经济体位于该地区，例如东南亚国协。

在亚太地区，公众健康意识的提高以及新型血液采样方法使用市场的快速发展正在推动未来几年的成长。

由于老年人和目标人口数量不断增加、研发成本不断上升以及糖尿病治疗意识不断增强，预计北美将占据全球采血采血针市场的大部分。此外，根据联合国《2019年世界人口展望》数据，65岁及以上人口比例预计将从2019年的9%增加到2050年的16%以上。此外，到 2050 年，80 岁及以上的人口数量预计将增加两倍（1.43 亿对 4.26 亿）。因此，随着老年人口的增加，由于老年人更容易患慢性病，慢性病预计将变得更加普遍，从而推动采血采血针的区域市场。在欧洲，随着人口老化日益增长的需求，国内企业正在增加併购策略投资并加剧竞争，进一步推动未来几年的市场成长。

为什么要购买这份报告？

  • 富有洞察力的分析：获得涵盖关键和新兴地区的深入市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、行业和其他子区隔。
  • 竞争格局：了解世界主要企业采取的策略策略，并了解透过正确的策略渗透市场的潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中释放新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业有用且具有成本效益。

它有什么用？

产业和市场考量、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022年至2030年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略和市场占有率分析
  • 区域收益成长和预测分析，包括细分市场和国家
  • 公司简介（主要是策略、产品、财务资讯、主要动态等）

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程
  • 资料检验

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章 血采血针市场：依类型

  • 介绍
  • 个人采血采血针
  • 安全采血采血针

第六章 采血采血针市场：依应用分类

  • 介绍
  • 血糖测试
  • 血红素测试
  • 其他用途

第七章 血采血针市场：依最终用户分类

  • 介绍
  • 医院/诊所
  • 血库
  • 居家照护
  • 其他的

第八章 血采血针市场：依地区

  • 世界概况
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东/非洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 併购/协议/合作
  • 竞争对手仪表板

第十章 公司简介

  • Becton, Dickinson, and Company
  • B. Braun Melsungen AG
  • Terumo Europe NV
  • Owen Mumford Ltd
  • Messe Dusseldorf GmbH
  • SteriLance Medical（Suzhou）Inc
  • Medline Industries, Inc
  • FL Medical SRL
简介目录
Product Code: KSI061613504

The blood lancets market is estimated to grow at a CAGR of 8.50% to reach a market size of US$3.083 billion in 2030 from US$2.050 billion in 2025.

Blood lancets are small medical implements for carrying blood samples or obtaining small specimens for testing. The increasing prevalence of diabetes and other infectious diseases worldwide is driving market growth during the forecast period.

However, the lack of reimbursement scenarios in developing countries is anticipated to restrain the market expansion in the coming years.

Blood lancets market drivers:

  • The rising prevalence of diabetes is driving the growth of the market

The rising prevalence of diabetes is expected to be one of the prime drivers of the market's growth during the forecast period. According to the IDF Diabetes Atlas' tenth edition for 2021, 537 million adults (20-79 years old) had diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. Additionally, type 2 diabetes is more likely to occur in 541 million adults. In addition, the rising economic burden of diabetes coupled with increasing healthcare expenditure worldwide is also anticipated to increase the demand for rapid diagnostic kits for glucose monitoring in the coming years. According to the International Diabetes Federation (IDF), global healthcare expenditure on diabetes was around US$966 billion in 2021, representing a growth of 9%, directly fueling the market's growth.

Blood lancets market geographical outlook:

By geography, the blood lancets market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The major economies like China, Japan, India, and South Korea dominate the Asia-Pacific region. Some of the fastest-growing emerging economies are from this region, such as ASEAN countries.

In the Asia Pacific region, increasing health awareness among the population coupled with the rapid market evolution in using new types of blood sampling methods is propelling its growth in the coming years.

North America is anticipated to dominate a large portion of the global blood lancet market because of its growing elderly and targeted populations, increasing R&D costs, and rising diabetes treatment awareness. In addition, the percentage of individuals over 65 is expected to rise from 9 percent in 2019 to more than 16 percent in 2050, according to figures from the United Nations' World Population Prospects in 2019. In addition, it is expected that by 2050, there will be three times as many people aged 80 or older population (143 million vs. 426 million). As a result, as the elderly population grows, chronic diseases are predicted to become more prevalent because older people are more likely to develop them, propelling the regional market for blood lancets. In Europe, domestic players are increasing strategic investment in mergers and acquisitions, increasing the competition and further propelling market growth in the coming years to address the growing needs of the region's aging population.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The blood lancets market is analyzed into the following segments:

By Type

  • Personal Blood lancets
  • Safety Blood lancets

By Application

  • Glucose Testing
  • Hemoglobin Testing
  • Other application

By End User

  • Hospitals &Clinics
  • Blood Banks
  • Homecare
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Rest of the Middle East and Africa
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process
  • 2.3. Data Validation

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. BLOOD LANCETS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Personal Blood lancets
  • 5.3. Safety Blood lancets

6. BLOOD LANCETS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Glucose Testing
  • 6.3. Hemoglobin Testing
  • 6.4. Other application

7. BLOOD LANCETS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals &Clinics
  • 7.3. Blood Banks
  • 7.4. Homecare
  • 7.5. Others

8. BLOOD LANCETS MARKET BY GEOGRAPHY

  • 8.1. Global Overview
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Rest of South America
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Rest of Europe
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. United Arab Emirates
    • 8.5.3. Rest of the Middle East and Africa
  • 8.6. Asia-Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Rest of Asia-Pacific

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Becton, Dickinson, and Company
  • 10.2. B. Braun Melsungen AG
  • 10.3. Terumo Europe NV
  • 10.4. Owen Mumford Ltd
  • 10.5. Messe Dusseldorf GmbH
  • 10.6. SteriLance Medical (Suzhou) Inc
  • 10.7. Medline Industries, Inc
  • 10.8. F.L. Medical SRL